Home
Company
About us
Genito-urinary diseases
Governance
Board of Directors
Scientific Advisory Board
Management
R&D
Pipeline
Litoxetine (IXA-001)
IXA-002 & IXA-003
MAGenTA
Press
Contact
octobre 18
, 2017
18 octobre 2017
Press Release, Ixaltis-IND, October 2017